Cardiac Amyloidosis
Background: Cardiac amyloidosis (CA) is a relatively rare and often undiagnosed cause of infiltrative cardiomyopathy. Although CA patients can present with heart failure-like symptoms,it is important for cardiovascular nurses to have a comprehensive understanding of the unique features of CA and the care of these patients across the illness trajectory.
Purpose: Our goals are to increase awareness of CA and to provide cardiovascular nurses with an evidence-based, clinical resource on the care of patients with CA.
Methods: This document is grounded in a review of recent evidence and practices guidelines, as well as the clinical insights of a team of cardiovascular nurses and nurse practitioners from across Canada, with experience in caring for CA patients.
Conclusion: This resource, including current evidence related to the pathophysiology, risk factors, clinical manifestations, diagnostic evaluation, medical and nursing management, and key clinical practice points, will ideally optimize care and outcomes for the unique CA patient population.
To view an English copy of the publication, please click here. For the French publication, please click here.
Cardiac Amyloidosis: An Overview for Patients
Please clear here to access a plain language summary to be shared with Patients.